Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/27/2026 | CALL | $26.00 | 7,294 | +7,033 | +2,694.64% |
| 03/20/2026 | CALL | $27.00 | 72,044 | +5,685 | +8.57% |
| 04/17/2026 | CALL | $27.00 | 35,684 | +3,290 | +10.16% |
| 03/20/2026 | CALL | $27.50 | 12,290 | +1,992 | +19.34% |
| 03/27/2026 | PUT | $26.00 | 8,765 | +1,559 | +21.63% |
| 03/20/2026 | PUT | $26.50 | 5,068 | +1,142 | +29.09% |
| 12/17/2027 | CALL | $32.00 | 4,772 | -146 | -2.97% |
| 01/21/2028 | CALL | $30.00 | 18,537 | -161 | -0.86% |
| 01/15/2027 | CALL | $30.00 | 39,575 | -177 | -0.45% |
| 12/17/2027 | CALL | $35.00 | 11,942 | -201 | -1.66% |
| 03/20/2026 | CALL | $26.00 | 25,044 | -226 | -0.89% |
| 03/20/2026 | CALL | $28.00 | 75,930 | -614 | -0.80% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.02% | 170.64M | 6.14B |
| Vanguard 500 Index Fund | 2.30% | 129.76M | 4.67B |
| Washington Mutual Investors Fund | 1.42% | 80.41M | 2.89B |
| Fidelity 500 Index Fund | 1.09% | 61.54M | 2.21B |
| SPDR S&P 500 ETF Trust | 1.08% | 60.77M | 2.19B |
| American Balanced Fund | 1.00% | 56.61M | 2.04B |
| Income Fund of America Inc | 0.93% | 52.68M | 1.9B |
| iShares Core S&P 500 ETF | 0.89% | 50.1M | 1.8B |
| Vanguard Index-Value Index Fund | 0.86% | 48.51M | 1.75B |
| Vanguard Specialized-Health Care Fund | 0.86% | 48.32M | 1.74B |
Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients
03/17 10:39 am
Benzinga
Read moreShould You Avoid Pfizer? Here's the Key Risk to Watch
03/17 01:15 am
The Motley Fool
Read moreAmgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
03/16 07:19 am
Benzinga
Read moreOlema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
03/16 07:00 am
GlobeNewswire Inc.
Read moreBridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
03/10 02:49 pm
Benzinga
Read more2 Healthcare Stocks That Are Too Cheap to Ignore
03/10 12:23 pm
The Motley Fool
Read moreBioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
03/10 08:40 am
Benzinga
Read moreNeumega (Pfizer, (Wyeth Pharmaceuticals)) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/10 05:53 am
GlobeNewswire Inc.
Read morePegasys (Roche, pharmaand) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/10 05:51 am
GlobeNewswire Inc.
Read moreWhere Will Eli Lilly Stock Be in 10 Years?
03/07 12:15 pm
The Motley Fool
Read moreHere's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks
03/07 02:15 am
The Motley Fool
Read moreHere's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
03/06 10:15 pm
The Motley Fool
Read moreChina Clears Weight-Loss Shot As Pfizer Enters Crowded Market
03/06 09:14 am
Benzinga
Read moreSkeletal Dysplasia Market - Global Forecast 2026-2032: $5.37 Bn Opportunities Driven by Advancing Diagnostic Precision, Integrated Therapies, Evidence Generation, and Equitable Access
03/05 05:51 am
GlobeNewswire Inc.
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreGLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities
03/04 06:48 am
GlobeNewswire Inc.
Read moreShould You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
03/03 04:14 pm
The Motley Fool
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read moreForget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
03/01 01:03 pm
The Motley Fool
Read moreHere's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole
02/27 07:22 pm
The Motley Fool
Read moreA Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
02/27 03:52 pm
GlobeNewswire Inc.
Read moreOne in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data
02/27 01:31 pm
GlobeNewswire Inc.
Read morePatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
02/26 02:35 pm
GlobeNewswire Inc.
Read moreJuvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
02/26 08:00 am
GlobeNewswire Inc.
Read moreEli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know.
02/25 03:15 pm
The Motley Fool
Read morePfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment
02/25 02:22 pm
Benzinga
Read moreAdvanced Drug Delivery Market to Grow 10.2% Annually Through 2030
02/25 01:54 pm
GlobeNewswire Inc.
Read moreGlobal Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036
02/25 10:00 am
GlobeNewswire Inc.
Read moreThis Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
02/24 10:30 am
The Motley Fool
Read moreModerna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot
02/20 12:02 pm
Benzinga
Read moreGlucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies
02/20 06:53 am
GlobeNewswire Inc.
Read moreSexual Health Supplement Market Report 2026-2035: Market to Reach $5.31 Billion by 2030, Driven by Biotechnology Innovation, Transparency in Ingredient Traceability and Gender-Specific Expansion
02/20 06:49 am
GlobeNewswire Inc.
Read moreTurner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider
02/18 06:55 am
GlobeNewswire Inc.
Read morePfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial
02/17 11:15 am
Benzinga
Read moreGlobal Fibrin Sealant Market Size to Reach USD 3.57 Billion by 2035 with 8.37% CAGR – SNS Insider
02/17 04:51 am
GlobeNewswire Inc.
Read moreUterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
02/16 09:00 am
GlobeNewswire Inc.
Read moreWhat Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years?
02/14 03:25 pm
The Motley Fool
Read moreMeet the 6.3% Yield Dividend Stock That Could Soar in 2026
02/13 07:32 am
The Motley Fool
Read moreTetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica
02/10 06:55 am
GlobeNewswire Inc.
Read moreStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
02/09 02:15 am
GlobeNewswire Inc.
Read moreGute Verkaufszahlen für Cresemba® (Isavuconazol) in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus
02/09 02:15 am
GlobeNewswire Inc.
Read more3 Healthcare Stocks Paying the Highest Dividends of 2026
02/06 04:15 pm
The Motley Fool
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreObesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally
02/05 05:00 am
GlobeNewswire Inc.
Read moreHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
02/05 04:57 am
GlobeNewswire Inc.
Read moreWill the Market Crash in 2026? Here's What History Says and What to Do About It
02/04 12:15 am
The Motley Fool
Read moreWhy 2026 Could Be the Year Pfizer's Stock Finally Takes Off
02/03 10:29 pm
The Motley Fool
Read moreWhy Pfizer Stock Dropped Today
02/03 12:16 pm
The Motley Fool
Read morePfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops
02/03 09:50 am
Benzinga
Read moreOTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - Privacy, Digital Access, and Rapid Results Accelerate Adoption
02/03 09:00 am
GlobeNewswire Inc.
Read more